Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Hanwha Aerospace (012450) Announces New Listing and Detailed Schedule of Preemptive Subscription Rights ‘Hanwha Aerospace 23R’

Posted on June 11, 2025July 20, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Aerospace (012450) Announces New Listing and Detailed Schedule of Preemptive Subscription Rights ‘Hanwha Aerospace 23R’

Fact Source: Financial Supervisory Service DART / 2025-06-11

Disclosure Type: New Listing of Preemptive Subscription Rights

💡 3-Second Summary

A total of 3,373,784 preemptive subscription rights (Hanwha Aerospace 23R) for Hanwha Aerospace’s paid-in capital increase will be listed on June 16, 2025, and traded until June 23, 2025. The expected issuance price per target share is KRW 684,000, and the subscription period is scheduled from July 1 to July 2, 2025.

📊 1. [Summary of Core Disclosure Content and Major Figures]

  • Listed Security: Hanwha Aerospace 23R Preemptive Subscription Rights
  • Trading Period: The listing date is 2025-06-16, and the delisting date is 2025-06-23.
  • Number of Subscription Rights: A total of 3,373,784 rights.
  • Target Share Information: Registered Hanwha Aerospace Common Stock, with an expected issuance price of KRW 684,000 per share.
  • Subscription Schedule: The subscription opens on 2025-07-01 and closes on 2025-07-02.
  • Identification Codes: Standard Code KRA0124501F9, Short Code J0124501F.

📈 2. [Expert View: What This Disclosure Means for Investors]

This filing provides information regarding the specific listing schedule and volume of the preemptive subscription rights issued during Hanwha Aerospace’s common stock paid-in capital increase. The number of listed rights is 3,373,784, and the expected issuance price for the underlying common stock is set at KRW 684,000 per share.

According to the disclosed details, the schedule is fixed for the subscription rights to be listed on June 16, 2025, and delisted on June 23, 2025. Furthermore, the subscription period for the underlying shares based on these rights is announced to run from July 1 to July 2, 2025. Investors should focus on tracking whether the administrative procedures are executed in accordance with the timelines stated in this official filing.

📝 Editor’s Comment (by K-STOCK Editor)

Hanwha Aerospace’s latest disclosure officially provides the exact listing volume and trading timeframe for the ‘Hanwha Aerospace 23R’ preemptive rights in accordance with its capital raising process. The total number of subscription rights stands at 3,373,784, with an expected issuance price of KRW 684,000 per share.

The primary objective checkpoint for investors going forward is adherence to the specified dates. The trading window for these subscription rights is strictly limited from June 16 to June 23, 2025, and trading will no longer be available after the delisting date of June 23.

Additionally, because the KRW 684,000 per share noted in this filing is designated as an ‘expected issuance price,’ investors must verify future regulatory updates regarding the final finalized price prior to the stated subscription dates (July 1–July 2, 2025).

📢 Disclaimer and Source Information

Source: This content was structured and newly written based on the official data submitted to the Electronic Disclosure System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This information is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] Samsung Biologics(207940) Signs KRW 102.5B (USD 75.4M) CMO Contract with European Pharmaceutical Company
Next Post: [Disclosure] HANMI Semiconductor (042700) Finalizes 1.3M Share Cancellation: Relisting on June 18 to Formally Lift Shareholder Value by 1.3%

Related Posts

[Disclosure] Jusung Engineering (036930) Faces Temporary Trading Halt in Equities and Derivatives Following Split-off Disclosures Semiconductors
[Disclosure] SK Hynix (000660) – (Correction) Extends Capital Contribution Period for Chinese Subsidiary SK hynix Semiconductor (China) Ltd. Disclosures
[Disclosure] Samsung Electronics(005930) Resolves to Dispose of 1,083,434 Treasury Shares for Employee Stock Compensation (Worth Approx. KRW 344.5 Billion) Disclosures
[Disclosure] Hanwha Ocean (042660) Announces Subsidiary Hanwha Ocean USA Holdings Corp. to Acquire Shares of Affiliate for KRW 185.75B Disclosures
[Disclosure] Hanwha Aerospace (012450) Files Amendment Revising Intercompany Loan Amount to KRW 636.3B for Singapore Affiliate Disclosures
[Disclosure] Celltrion (068270) Decides to Dispose of 11,379 Treasury Shares Worth KRW 1.65B for Stock Option Settlements Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme